Immunosuppressed persons such as HIV/AIDS patients are at risk of acquiring diarrhoeal infections from water-borne E. coli O157:H7. In the present study, we investigated the prevalence of E. coli O157:H7 in drinking water collected from selected distribution systems within the Amathole District of the Eastern Cape and its predicted impact on diarrhoeic conditions of HIV/AIDS persons living in this area. One hundred and eighty water samples and 360 stool swabs from confirmed and nonconfirmed HIV/AIDS diarrhoeic patients were analysed. Escherichia coli O157:H7 were isolated using enrichment culture and confirmed using molecular techniques.
Introduction
Safe drinking water that complies with the South African National Standards (SANS) 241 Drinking Water Specification (SANS, 2001) does not pose a significant risk to public health (especially for babies, infants, immunosuppressed persons such as HIV/AIDS individuals, and the elderly) over a lifetime of consumption. This is the norm in almost all South African metropolitan areas. However, in many rural and some peri-urban areas, the situation is very different. Prior to 1994, 30 to 40% of the South Africa's population (approximately 14 to 18 m. people) was without adequate water supply. As recently as 2004, some 4 m. people were still obtaining water from rivers, ponds and springs, (Kasrils, 2004) , which were usually not treated and were faecally contaminated (Muyima and Ngcakani, 1998; Momba and Kaleni, 2003; Momba and Notshe, 2003) . While the present South African Government has implemented many rural water supply schemes under the National Reconstruction and Development Programme, where rural water supplies do exist, drinking water is often of poor quality and considered unsafe 2004a; 2005a; 2006a; Obi et al., 2006) . This means that consumers are at risk of contracting water-borne diseases even from treated water supplies.
By the year 2002, a large proportion of the Eastern Cape population (68%) still lived below the South African national poverty line (UNDP, 2004) and approximately 11% and 38% of the population lived in informal and traditional structures, respectively. Piped water distribution had reached only 62% of households and 31% of households had no toilet facilities (Statistics South Africa, 2003) . The Amathole District Municipality, where this research was conducted, is in the Eastern Cape Province, which is home to 12.1% of HIV positive persons in South Africa (Dorrington et al., 2006) . By June 2006 , Dorrington et al. (2006 reported that the majority of these HIV-positive individuals in the Eastern Cape Province were youths with an estimated prevalence of 16.4%. The predicted incidence of HIV infections in the Eastern Cape Province is at 1.3% and as at June 2006, 194 443 people had died of HIV/AIDS and another 64 095 people were already sick with the disease (Dorrington et al., 2006) . However, it is not only HIV/AIDS that has ravaged the Eastern Cape community; other diseases such as strokes, hypertensive heart disease, diarrhoeal diseases, diabetes mellitus and tuberculosis have also been reported (Bradshaw et al., 2000) .
The World Health Organization (WHO) estimated that about 88% of diarrhoeal diseases in the world are attributed to unsafe water, sanitation and hygiene. Approximately 3.1% of annual deaths (1.7 m.) and 3.7% of the annual health burden (disabilityadjusted life years [DALYSs] ) worldwide (54.2 m.) are attrib-366 uted to unsafe water, sanitation and hygiene (WHO, 2003) . The impact of diarrhoeal diseases is significant in South Africa, with annual estimated deaths of about 50 000. Three million cases of illnesses and treatment cost the state about R3.4 bn. (Pegram et al., 1998; Mackintosh et al., 2002; Sapkota et al., 2004) . The most alarming situation is the death of about 20% of all children under 5 years of age living in settlements with access to rudimentary water supply and sanitation (Bourne and Coetzee, 1996) .
Diarrhoea occurs in about 30 to 60 % of HIV/AIDS patients in developed countries and in an estimated 90% of such patients in developing countries (Sapkota et al., 2004) . Epidemiological investigations during outbreaks have identified E. coli O157:H7 as a pathogenic strain that causes severe and life-threatening diarrhoea (Galane and Le Roux, 2001) . Escherichia coli O157:H7 infections pose the greatest risk to immunosuppressed individuals because it can easily invade the cells of HIV/AIDS patients due to a suppressed cell-mediated immunity (Morris and Potter, 1997; Hoffman, 2004) . One of the easily discernable consequences of HIV/AIDS is the long-term implications for effective water resource management and the provision of wholesome water supplies to communities (Ashton and Ramasha, 2002) .
Although HIV/AIDS and water-borne diarrhoeal diseases are among the leading causes of morbidity and mortality in South Africa, the association of diarrhoea disease-causing agent such as E. coli O157:H7 in drinking water and the diarrhoeal conditions of HIV/AIDS individuals still remains unknown in South Africa. We, therefore, conducted the present study to ascertain the prevalence of E. coli O157:H7 in drinking water collected from selected distribution sources within the Amathole District of the Eastern Cape Province and its predicted impact on diarrhoeic conditions of HIV/AIDS persons living in this area.
Experimental

Study site
The study was conducted between March 2005 and August 2006. The Amathole District was selected based on the researchers' familiarity with the area, HIV prevalence and the presence of a referral hospital, Frere Hospital, which is situated in the City of East London and caters for HIV/AIDS patients of various races, gender and age groups from rural areas of the district. Fort Beaufort, Alice, Dimbaza, Mdantsane, Ngwenya and Kwasaki were chosen because potential pathogenic E. coli strains have been reported to be predominant in water sources used by these communities (Momba and Kaleni, 2003; Momba and Notshe, 2003; Momba et al., 2004a; 2005a; .
Scientific ethics and informed consent
The University of Fort Hare's Govan Mbeki Research and Development Centre, the Provincial Department of Health (Bisho), and the Regional Eastern Cape Ethical Review Committees all approved the protocol that was used for the stool swab collection. Informed consent was obtained from patients or their guardians with the help of a nurse with voluntary counselling and testing (VCT) skills and experience.
Collection of samples
In total, 180 water samples (30 for each site) were collected from the standpipes that supplied treated drinking water to the communities of Fort Beaufort, Alice, Dimbaza, Mdantsane, and untreated groundwater to the communities of Ngwenya and Kwasaki, using internationally accepted techniques and principles.
Three hundred and sixty stool swabs were obtained from confirmed HIV/AIDS positive (180 stool swabs) and non-confirmed HIV/AIDS (180 stool swabs) diarrhoeic patients visiting Frere Hospital for treatment, using sterile cotton swabs (Merck, Johannesburg, SA). The stools swabs were dipped in sterile specimen bottles filled with 30 m of 1% (w/v) sterile saline solutions (Merck, SA). The confirmed HIV/AIDS patients had already been tested for HIV at the HIV/AIDS clinic of Frere Hospital and were known by the hospital clinicians to be carriers of the HIV virus. The patients' locations and their diarrhoeal conditions and HIV/AIDS status were recorded. Anonymity of the patients was protected as much as possible. Diarrhoeic stools in this study were diagnosed in the case of patients experiencing three or more watery stools in 24 h. The water samples and stool swabs were transported on ice in a cooler box and transported to the laboratory for the isolation of E. coli O157:H7. Microbiological analyses were performed within 1 to 4 h of their collection.
Isolation of E. coli O157:H7
Escherichia coli O157:H7 from water samples and stool swabs of patients was isolated using a pre-enrichment process followed by immunomagnetic separation and spread-plate procedure. For pre-enrichment, 1 mℓ of water sample or saline stool swab suspension was added to 99 mℓ of modified E. coli (mEC) broth containing 20 µg·mℓ -1 of Novobiocin (n) (Merck, SA) (Heuvelink et al., 1998). The samples were incubated for 8 h at 37 o C on a rotary shaker (143 × g) (Gallenkamp, Loughborough, England). Thereafter, 1 mℓ of pre-enriched water sample or stool swab suspension was added to an Eppendorf tube(Eppendorf, SA) containing 20 µ·mℓ -1 of magnetic beads coated with antibody to O157. Immunomagnetic separation (IMS) proceeded as described by the Dynabead manufacturer (Dynal Product Brochure, 2006) . The bacterial-IMS bead complex were re-suspended into 1% (w/v) sterile Phosphate Buffered Saline (PBS) (Merck, SA) and 50 µℓ of this bacterial-IMS concentrate was spread in duplicate onto Sorbitol-MacConkey agar supplemented with cefixime (0.05 mg·mℓ -1 ) and potassium tellurite (2.5 mg·mℓ -1 ) (CT-SMAC) (Merck, SA) agar plates (Müller et al., 2003) . The plates were then incubated at 37°C for 24 h. Sorbitol-non-fermenting colonies (up to 5 colourless colonies per plate per sample) were randomly selected and further plated onto Eosin Methylene Blue (EMB) agar (Merck, SA). Forty six water samples and 74 and 57 stools from confirmed and non-confirmed HIV/AIDS patients respectively, had presumptive E. coli O157 with greenish blue black metallic sheen on EMB agar.
Identification of E. coli O157
Escherichia coli O157 colonies were identified as described by Cagney et al. (2004) . The Oxidase test was performed on the colonies that were Gram negative prior to the conventional indole-methyl red-Voges-Proskauer-citrate (IMViC) tests (Heuvelink et al., 1998; Müller et al., 2003) . Colonies of presumptive E. coli O157 each representing the 46 water samples and 74 and 57 stool samples from confirmed and non-confirmed HIV/AIDS patients respectively, were subjected to IMViC test and further confirmed as E. coli with API 20E kits.
The strips were read and final identification was secured using API LAB PLUS computer software (BioMérieux, Marcy- (Momba et al., 2006b) . Of the 46 water samples, 74 and 57 stool swabs of confirmed and non-confirmed HIV/ AIDS patients, respectively, only 27, 25 and 29 representative E. coli O157 from these respective samples had 99.9% profile for E. coli with API PLUS computer software program, thus these were used for molecular characterisation.
Molecular characterisation of E. coli O157:H7 using polymerase chain reaction (PCR)
Bacterial DNA extraction DNA was extracted from colonies identified as E. coli O157 and also from a positive control strain (E. coli O157:H7, ATCC 43895) purchased from the Microbiology Department of the National Health Laboratory Services (NHLS), Johannesburg, South Africa. The extraction was performed according to the method previously used by Torres et al. (2003) . Briefly, a loopfull of overnight culture of E. coli colonies was suspended in 200 µℓ of sterile Milli-Q PCR grade water (Merck, SA) and the cells were lysed using a Dri-block DB.2A (Techne, Cape Town, SA) for 15 min at 100 o C. The cell debris was removed by centrifugation at 20 000 × g for 2 min using a MiniSpin micro-centrifuge (Merck, SA). The lysate supernatant was placed on ice for 5 min. Sterile Milli-Q PCR grade water (Merck, SA) was included in each PCR assay as a negative control.
Amplification of fliC H7, rfbE O157 and eaeA genes Oligonucleotide primers specific for the targeted fliC H7, rfbE O157 and eaeA genes used in the polymerase chain reaction (PCR) were similar to those used by Wang et al. (2002) (Table 1) . Three sets of primer mixtures were prepared according to the method used by Wang et al. (2002) . A total volume of 10 μℓ genomic DNA was used in each PCR reaction. The PCR assays for fliC H7 , rfbE O157 and eaeA genes were carried out in a 50 μℓ reaction volume containing 10× SuperTherm GOLD Buffer, 1.5 mM MgCl 2 , each of the four deoxynucleoside triphosphates (dNTPs) (Southern Cross Biotechnology, SA) at a concentration of 0.25 mM, 100 pmol for each of fliC H7, rfbE O157 and eaeA specific primers, and 5 U of Taq DNA polymerase (Southern Cross Biotechnology, SA).
The reaction was carried out in the Eppendorf model AG 22331 Thermocycler (Merck, SA). The following PCR conditions for fliC H7 , rfbE O157 and eaeA genes optimised in our laboratory were similar to those previously used by Wang et al. (2002) . Initial denaturation at 95°C for 8 min; followed by 30 cycles of amplification, denaturation at 95°C for 30 s, annealing at 58°C for 30 s, and extension at 72°C for 30 s. The final extension cycle was followed by incubation at 72°C for 7 min and cooling to 4°C.
DNA electrophoresis
The amplicons (10 μℓ aliquots) were visualised on a 2% (w/v) agarose gel (Merck, SA) in 1 U TAE buffer (40 mM Tris-HCl, 20 mM Na-acetate, 1 mM EDTA, pH 8.5) and stained with 0.5 µg . mℓ -1 ethidium bromide (EtBr) (Merck, SA). The amplified products were photographed under the BioDoc-It System (UVP Upland, CA 91786, USA). A 100-bp DNA ladder (Promega, Madison, USA) was included on each gel as a molecular size standard. The electrophoresis was carried out at 76 V for 1 h.
Statistical analysis
The statistical analysis was done by use of SAS program (SAS Institute, Cary, NC). The Chi square test was used to establish the significance difference between the prevalence rates of E coli O157:H7 in stool samples of confirmed HIV/AIDS patients and those of non-confirmed HIV/AIDS patients. The Chi square test was run at a statistical significance level of (P ≤ 0.05).
Results
Prevalence of E. coli O157 in water samples
Of the 180 drinking water samples, 46 (25.56 %) were positive for E. coli O157. Water samples collected from Fort Beaufort, Alice and Dimbaza, Mdantsane, Ngwenya and Kwasaki were positive at prevalence rates of 16.67% (5/30), 30% (9/30), 30% (9/30), 13.33% (4/30), 36.67% (11/30) and 26.67% (8/30) respectively (Fig. 1) . Prevalence of E. coli O157 in stool specimens of diarrhoeic patients
Of the 360 stool swabs of diarrhoeic patients, 131 (36.39%) were positive for E. coli O157. About 56.5% (74/131) were from confirmed HIV/AIDS diarrhoeic patients and 43.5% (57/131) were from non-confirmed HIV/AIDS diarrhoeic patients (Fig. 2) . By location, the prevalence of E. coli O157 was at 75.7% (56/74) for confirmed HIV/AIDS patients and 73.6% (42/57) for non-confirmed HIV/AIDS patients originating from East London.
Another location that had a noticeable prevalence of E. coli O157 for the confirmed HIV/AIDS patients was Stutterheim 4.05% (3/74) whereas locations such as Duncan Village and Mdantsane had a prevalence of 2.7% (2/74). The rates of E. coli O157 prevalence for the other locations of the non-confirmed HIV/AIDS patients were 5.26% (3/57) for Butterworth, 3.51% (2/57) for Duncan Village, King Williams Town and Stutterheim whereas Mdantsane had no E. coli O157. Localities, which had very low numbers of patients, were categorised as 'Others' and E. coli O157 prevalence for confirmed HIV/AIDS patients from such locations was 9.5% (7/74) whereas for the non-confirmed HIV/AIDS patients the prevalence was 8.77% (5/57). Although the study focused on the Amathole District Municipality and the majority of the patients who visited Frere Hospital originated from this district, some of the patients originated from other districts ( Table 2 ). The χ 2 value of 0.058 predicted that HIV/AIDS status was a significant variant for E. coli O157 infection. The arguments were based on the statistical significance level at which the χ 2 test was run (P ≤ 0.05).
Molecular characterisation of isolates
Water samples isolates identified by biochemical profiles for E coli O157 that were positive by PCR for fliC H7, rfbE O157, and eaeA genes characteristics of E. coli O157:H7 are summarised in Table 3 . Of the 27 water samples positive for E. coli O157 isolates, 4 (14.81%) carried fliC H7, rfbE O157 and eaeA genes whereas 3.70% (1/27) was only positive for fliC H7 gene. The three target genes of E. coli O157:H7 (fliC H7, rfbE O157, and eaeA) under the present study were noticed in isolates obtained from Dimbaza, Fort Beaufort, Ngwenya and Mdantsane water samples. Representative gel electrophoretic profiles of amplified products of target genes for E. coli O157:H7 are illustrated in Fig. 3 . 
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Molecular analysis of isolates obtained from stool specimens of diarrhoeic patients revealed that fliC H7 , rfbE O157 and eaeA genes were present in 9 of the 25 (36%) E. coli O157 isolates from stool swabs of confirmed HIV/AIDS diarrhoeic patients (Table 4) . On the other hand, only 5 of the 29 (17.24%) of E. coli isolates from stool swabs of non-confirmed HIV/AIDS diarrhoeic patients carried fliC H7 , rfbE O157 and the attaching and effacing (eaeA) genes (Table 5) . Representative gel electrophoretic profiles of amplified products of target genes for E. coli O157:H7 are illustrated in Fig. 4 .
Discussion and conclusion
The present study revealed important findings on the prevalence of E. coli O157 in the drinking water supplied to the communities of Fort Beaufort, Alice, Dimbaza, Mdantsane, Ngwenya and Kwasaki. A higher E. coli O157 prevalence rate was noted in water samples collected from Ngwenya groundwater samples (36.66%) while a lower prevalence rate was recorded in Fort Beaufort treated drinking water samples (16.66%) (Fig. 1) . With the exception of the water samples collected from Alice, which showed only one target gene ( fliC H7 ) (Table 3) , the PCR successfully amplified the three target genes ( fliC H7, rfbE O157 and eaeA) of the E. coli O157:H7 from the isolates obtained from the drinking water samples (Table 3, Fig. 3) .
The results of this study confirm the poor microbiological quality of the drinking water that is produced by many water 
